Medical News

RSS

New, fully-automated morphological system offers improved breast cancer detection

The launch of Invivo Corporation's ONCAD for DynaCAD marks the availability of the first FDA-cleared, fully-automated morphological system for the detection and analysis by a radiologist of suspicious breast lesions. The ONCAD system will be officially unveiled at the Radiological Society of North America 2009 Annual Meeting in Chicago.

1 Dec 2009

Third-quarter fiscal 2009 results announced by Urodynamix Technologies

Urodynamix Technologies Ltd. today reported its financial results for its fiscal third quarter ended September 30, 2009. The Company reported a loss of $638,287 or $0.01 per share basic and diluted compared to a loss of $737,341or $0.01, basic and diluted, for the comparative quarter of the prior year. Revenue for the quarter ended September 30, 2009 at $15,285, decreased 55% over the same quarter of the prior year.

1 Dec 2009

FDA issues marketing clearance for the OIS EyeScan portable imaging device

Ophthalmic Imaging Systems, a leading digital imaging and informatics company, today announced that its revolutionary new portable imaging device, the OIS EyeScan, has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA).

1 Dec 2009

Thanx Media creates new website search tool for Scrubs & Beyond

A quick visit to Scrubs & Beyond's website and you will see that there have been some changes. Scrubs & Beyond went to Thanx Media for help in creating a new and improved website search engine.

1 Dec 2009

Tall and overweight children face increase risk of obesity in later years, says new study

Being tall and overweight, or just being tall, might be a marker in children for an increased risk of being overweight or obese in later years.

1 Dec 2009

Insurance customers have intentions to switch their Medicare coverage, finds study

A new study has found that 27% of Medicare Advantage and Supplemental Medicare insurance customers have a current intention to shop for and possibly switch their Medicare coverage.

1 Dec 2009

$2.6M NIH grant for survey of in situ protein-protein interaction networks

Our brain is composed of over one trillion cells called neurons. Each neuron contains millions of proteins. Exactly how individual proteins interact with one another and together form complex signaling networks within neurons has never been examined directly in live animals.

1 Dec 2009

High-frequency ultrasound with elastography improves skin cancer diagnosis

High-frequency ultrasound with elastography can help differentiate between cancerous and benign skin conditions, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2009

Kemin Foods, OmniActive settle patent dispute

Kemin Foods, L.C. ("Kemin") and OmniActive Health Technologies, Inc. and OmniActive Health Technologies, Ltd. ("OmniActive") have reached an amicable settlement of their dispute.

1 Dec 2009

GAA urges Obama to reflect on AIDS epidemic

On World AIDS Day 2009 the Global AIDS Alliance (GAA) calls on President Obama and his advisors to reflect on two recent alarming reports from the World Health Organization (WHO) showing that the AIDS pandemic continues to be of catastrophic proportion, affecting shockingly high numbers of people around the globe.

1 Dec 2009

MedQuist signs agreement with Nuance Communications

MedQuist Inc., a leading provider of technology-enabled clinical documentation services, today announced that it has signed an agreement with Nuance Communications, Inc. (Nuance) under which MedQuist will now license Nuance's SpeechMagic speech recognition engine and processing software for use in SpeechQ of General Medicine(TM), MedQuist's front-end speech recognition application for all medical disciplines.

1 Dec 2009

Clinical trail shows PAD patients also experience asymptomatic heart disease

Results of a randomized, controlled clinical trial presented today at the annual meeting of the Radiological Society of North America (RSNA) reveal that one in five patients with narrowing or blockage in arteries that supply blood to the legs and other parts of the body also have significant but silent coronary artery disease.

1 Dec 2009

GE Healthcare to investigate the performance of MBIR

GE Healthcare, a $17 billion unit of General Electric Company, announced today a multi-center study to investigate the performance of Model Based Iterative Reconstruction (MBIR) as a method to maintain or improve diagnostic information available to clinicians while dramatically lowering radiation dose in routine CT imaging.

1 Dec 2009

Medpro Imaging to launch new ultrasound systems at RSNA 2009

MedPro Imaging, a premium provider of new and refurbished ultrasound solutions, will showcase leading ultrasound solutions including the Mindray M5 laptop, GE Logiq I and Siemens X300 Premium Edition during the company's debut at the 95th Radiology Society of North America (RSNA) conference, being held in Chicago November 29 - Dec. 3, 2009.

1 Dec 2009

European Patent Office grants patent EP1392642 for 4SC AG's lead auto-immune compound

4SC AG, a drug discovery and development company, today announced that the European Patent Office has granted patent EP1392642, which covers its lead auto-immune compound 4SC-101.

1 Dec 2009

Patheon and JLL complete settlement agreement

The Special Committee of Independent Directors of Patheon Inc. ("Patheon" or the "Company") (TSX: PTI) and JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, LLC (collectively, "JLL"), today announced that the Company and JLL have entered into a settlement agreement in respect of the pending legal actions between the parties.

1 Dec 2009

Refuse to file letter on NDA for Cladribine Tablets issued to EMD Serono

EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that it received a refuse to file letter from the US Food and Drug Administration (FDA) on the New Drug Application (NDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for relapsing forms of multiple sclerosis (MS).

1 Dec 2009

Completion of Phase I study of CPSI-2364 announced by Cytokine PharmaSciences

Cytokine PharmaSciences, Inc. today announced the completion of a Phase I study of CPSI-2364, its orally active, small-molecule inhibitor of the production of TNF-alpha and other pro-inflammatory cytokines.

1 Dec 2009

Members of priority groups to receive H1N1 vaccines from Department of Health

The Department of Health reminded Pennsylvanians they can begin making appointments today to be vaccinated against the H1N1 flu virus.

1 Dec 2009

Intelliject announces an exclusive license with sanofi-aventis for epinephrine auto-injector

Intelliject, Inc. today announced an exclusive license with sanofi-aventis U.S. for a novel epinephrine auto-injector, in the U.S. and Canada territory. Under the license, sanofi-aventis U.S. shall be responsible for manufacturing and commercialization.

1 Dec 2009